Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775722 · ClinicalTrials.gov registry record · NA
Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01775722 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 22 participants.
The verdict
NCT01775722, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin. However, even though the pulsed dye laser is considered as the treatment of choice for Port wine stain Birthmark the degree of fading can remain variable and unpredictable after laser treatment.
Interventions
- DEVICE Pulsed Dye Laser
- DEVICE Combined Bipolar Radiofrequency&Pulsed Dye Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775722
The ClinicalTrials.gov registry entry for NCT01775722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pulsed Dye Laser is the first listed.
NCT01775722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01775722 about?
NCT01775722 is a clinical study titled "Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment". Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin. However, even though the pulsed dye laser is considered as the treatment of choice for Port wine stain Birthmark the degree of fading can remain variable and unpredictable after laser treatment.
What is the current status of trial NCT01775722?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01775722?
The interventions under investigation include: Pulsed Dye Laser (DEVICE), Combined Bipolar Radiofrequency&Pulsed Dye Laser (DEVICE).
Who is sponsoring clinical trial NCT01775722?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.